Key statistics dashboard for Bluejay Diagnostics, Inc. (BJDX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force.
Stock Data
| Price | $0.81 |
| Market Cap | $1M |
| Enterprise Value | -$8.7M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.07 |
| Price / Book | 0.19 |
| P/S | 0.00 |
| EV/EBITDA | 1.22 |
| EV/Sales | 0.00 |
| EV/FCF | 1.39 |
| P/FCF | -0.14 |
| Earnings Yield | -430.37% |
| FCF Yield | -742.08% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -125.01% |
| Return on Assets | -63.04% |
| Return on Invested Capital | -77.55% |
| Return on Capital Employed | -78.19% |
Financial Health
| Current Ratio | 4.64 |
| Quick Ratio | 4.64 |
| Cash Ratio | 4.53 |
| Debt / Equity | 0.01 |
| Debt / Assets | 0.70% |
| Net Debt / EBITDA | 1.33 |
| Interest Coverage | -19027.83 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -10.03 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 4.53 |
| Cash per share | 4.62 |
| FCF per share | -3.00 |
| Tangible Book Value per share | 4.53 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 0 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 0.00 |
Related companies: BCTXZ · ELAB · MLEC · MSPR · NKGN · TIVC · UPC
Explore sector: Healthcare · Medical - Devices
More sections of BJDX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks